Overview

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer